MedTrace Logo

Precision Exercise in Children With Malignant Hemopathies

NCT04090268 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2024-01-02

No results posted yet for this study

Summary

In the early years of life and during adolescence, physical activity is crucial for good development of motor skills. It is even more so for those children and young people who are forced to undergo anti-cancer therapies and therefore undergo long periods of hospitalization (often bedridden) and prolonged periods of physical inactivity.

The research project "Sport Therapy" was born with the aim of demonstrating that, through targeted physical activity administered by the sports physician in collaboration with the pediatrician hematologist, it is possible to facilitate the full recovery of these patients, avoiding the high risk of chronic diseases related to a sedentary lifestyle and allowing them to better reintegrate, once healed, in their community of origin (school, sport and social relations).

The research project "Sport Therapy" was born within the Maria Letizia Verga Center at the Pediatric Clinic of the University of Milan Bicocca, at the Foundation for the Mother and Her Child, San Gerardo Hospital in Monza. Every year, around 80 children and adolescents with leukemia, lymphoma or blood disorders leading to bone marrow transplantation are treated here.

Conditions

  • Leukemia, Myeloid, Acute
  • Leukemia, B-cell
  • Leukemia, T Cell
  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin
  • Drepanocytosis
  • Thalassemia Major
  • Adrenoleukodystrophy

Interventions

OTHER

Sport Therapy

Children and adolescent with malignant hemopathies will attend a 3 days/weekly combined training

Sponsors & Collaborators

  • Comitato Maria Letizia Verga,Italy

    collaborator UNKNOWN

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Andrea Biondi, MD, PhD · University of Milano Bicocca

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-03
Primary Completion
2025-04-03
Completion
2026-04-03

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090268 on ClinicalTrials.gov